The time has come for...The Native Antigen Company's December edition of The Monthly Infectious Disease Summary! We've pulled together this month's most relevant news articles, highly engaging podcasts, free digital downloads and more for you. So whether your on the lab bench or awaiting your results you can stay up to date by scrolling our newsletter. Read it now: https://hubs.ly/Q02_ZtQF0 #antigens #antibodies #infectiousdisease #newsletter
The Native Antigen Company
Biotechnology Research
Oxford, Oxfordshire 1,577 followers
Critical Reagents for Human Health
About us
At the Native Antigen Company we are experts in the development and manufacturing of infectious disease antigens from bacteria and viruses, and in the production of recombinant forms of these antigens using our proprietary mammalian expression system. These antigens are prepared for both research and development purposes, and also on bulk scale for IVD manufacturers to incorporate into their immunoassays. Our R&D team have particular expertise in flavivirus biology. We were the first in the world to develop mammalian expressed Dengue virus NS1 antigens, and then to develop Zika virus NS1 using the same platform. We have also developed a range of Virus-like particles, which are finding increasing applications as antigens for IVD applications. We continue to develop cutting edge antigens, and are also now using these antigens to raise highly specific monoclonal antibodies and to develop immunoassays. We also offer these services on a contract basis for customers who need a reliable source of high quality recombinant or native protein.
- Website
-
http://www.thenativeantigencompany.com
External link for The Native Antigen Company
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Oxford, Oxfordshire
- Type
- Privately Held
- Founded
- 2010
- Specialties
- infectious disease antigens, contract research, protein purification, contract development, zika virus R&D, mammalian recombinant protein expression, Immunoassay development, Monoclonal antibodies, and Dengue virus
Locations
-
Primary
Get directions
Langford Locks, Kidlington
Oxford, Oxfordshire OX5 1LH, GB
Employees at The Native Antigen Company
-
Tomas Richardson
Molecular microbiologist, protein biochemist & diagnostic specialist
-
Toni Ertl
Experienced immunoassay scientist and laboratory manager
-
Peter Turton
Commercial Laboratory, Supply Chain and Operations Manager
-
Adrian Stevens
Finance Director | Financial Controller | Life Sciences | Biotechnology
Updates
-
Rubella virus is notoriously difficult to culture and extremely challenging – and therefore costly – to propagate at scale. Rubella Virus-Like Particles (VLPs) hold huge potential as a scalable, cost-effective route to immunization for vaccine developers, and as a novel platform for rubella research and diagnostics. Want to know 'Why'? Click the link to get your free "Rubella Virus-Like Particles: The New Candidate of Choice for Diagnosing and Preventing Rubella" eBook: https://hubs.ly/Q02-DQnv0 #Rubella #VLP #eBook #nextgenerationvaccines
-
It's Here! The Native Antigen Company's November edition of The Monthly Infectious Disease Summary. Dive into this month's handpicked content of relevant news articles, revelated podcasts, newly released product offerings and more. Read this month's edition NOW by clicking the link: https://hubs.ly/Q02YmZx60 #antigens #antibodies #infectiousdisease #newsletter
-
-
It’s almost time! This Monday, we’ll be at MEDICA 2024 in Düsseldorf, running from November 11-14, at Booth #3C63. Our representatives are quickly filling their schedules, so don’t wait—book your meeting now! https://hubs.ly/Q02Xyd820 #MEDICA2024
-
-
LGC Clinical Diagnostics and LGC Biosearch Technologies are attending MEDICA - Leading International Trade Fair in Germany, November 11-14, come visit us at booth 3C63. Learn more about our diagnostics and genomics one-stop-shop, OR schedule a meeting with one of our representatives by clicking on this link: https://hubs.ly/Q02WS-HC0 #MEDICA2024
-
-
Oropouche virus is rapidly spreading across South and Central America, and the Caribbean. Protect public health with our Oropouche virus products including our NEW Oropouche Virus Nucleoprotein, C-terminal His-tag. Buy now: https://hubs.ly/Q02V8l-c0 #antigens #oropoucheoutbreak
-
-
Just Released! The Native Antigen Company is delighted to present the October edition of our Monthly Infectious Disease Newsletter. This curated collection features handpicked content from around the globe, including impactful news articles, insightful blogs, and engaging podcasts. Stay informed and inspired with each edition! Check out this month's edition by clicking the link: https://hubs.ly/Q02TKbZQ0 #antigens #antibodies #infectiousdisease #newsletter
-
-
It's that time of year again...Flu Season. Get started on your next influenza project with The Native Antigen Company 2024-25 Southern Hemisphere Antigens. This influenza profile offering includes the Haemagglutinin (HA) and Neuraminidase (NA) antigens and covers the 2025 southern hemisphere WHO recommendation on the Influenza Virus Vaccine Composition. It is now available on our website! Click the link to view the comprehensive list of antigens and purchase now: https://hubs.ly/Q02T6nXt0 #influenza #antigens
-
-
Stay Ahead of Flu Season with The Native Antigen Company's new H5N1 antigen, Now Available! This Avian Influenza A(H5N1) Clade 2.3.4.4b Hemagglutinin (HA) has been specifically developed to tackle the pressing challenges posed by the rapidly spreading H5N1 strain, a growing global concern due to its significant impact on poultry, wildlife, and human health. Click the link to visit our website and buy it now: https://hubs.ly/Q02RlTbl0 #newantigens #vaccineresearch #fluseason
-
-
This month's edition of our infectious disease newsletter is here! Check out our perspective on the most significant news of the month relating to disease, public health and technology by clicking here: https://hubs.ly/Q02QsD7v0 #infectiousdisease #news #antigensandantibodies
-